7,7′-Dihydroxy bursehernin inhibits the expression of inducible nitric oxide synthase through NF-κB DNA binding suppression

Yuba Raj Pokharel,Qing-He Liu,Dipendra Kumar Aryal,Yoon Gyoon Kim,Eun-Rhan Woo,Keon Wook Kang

DOI: https://doi.org/10.1016/j.niox.2006.10.006

IF: 4.898

2007-01-01

Nitric Oxide

Abstract:This study isolated a lignan, 7,7′-dihydroxy bursehernin, from Geranium thunbergii and investigated whether or not the lignan affects the induction of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in RAW264.7 macrophages stimulated with lipopolysaccharide (LPS). The gel shift analysis and luciferase reporter gene assays using the iNOS promoter and nuclear factor-κB (NF-κB) minimal promoter showed that a treatment with 7,7′-dihydroxy bursehernin reduced the reporter activities and binding of NF-κB to the NF-κB consensus sequence, while it had no effect on the nuclear translocation of p65 and the phosphorylation/degradation of I-κBα. It was reported that a few natural compounds directly suppressed the binding activity of the NF-κB components to DNA. The NF-κB binding activity was not reversed by the in vitro exposure of the nuclear extracts to 7,7′-dihydroxy bursehernin, which suggest that a metabolite(s) of 7,7′-dihydroxy bursehernin might target the binding of the NF-κB complex to the DNA binding domain region in the promoter region of the iNOS gene. After incubation of RAW264.7 cells with 7,7-dihydroxy bursehernin for 18h, the levels of parent compound were negligible; while a main metabolite, 4-[4-(n-hydroxy-phenyl)-2,3-dimethyl-buta-1,3-dienyl]-benzene-1,2-diol was detected in cell lysates and culture medium.